Navigation Links
Seven New Cholesterol Genes Discovered
Date:1/13/2008

Study finds only those that regulate LDL levels influence heart disease risk

SUNDAY, Jan. 13 (HealthDay News) -- Seven new cholesterol-regulating genes, some of which influence the risk of heart disease, have been identified in an international study of almost 20,000 people in three countries.

"I would predict that some of these genes will be the targets for future drugs," said the study's senior author, Goncalo Abecasis, an associate professor of biostatistics at the University of Michigan School of Public Health.

In their report, published in the Jan. 13 issue of Nature Genetics., the researchers also confirmed the role of 11 previously identified cholesterol-related genes in the risk of heart disease.

"What was most exciting was that only the genetic changes that affect LDL cholesterol influence the risk of heart disease," Abecasis said. "Every genetic change that raises the level of LDL cholesterol influences the risk of heart disease."

LDL cholesterol is well known to be the "bad" kind that forms plaques that eventually can block arteries, causing heart attacks and other cardiovascular troubles. LDL cholesterol is the target of statins, drugs given to reduce coronary risk. HDL cholesterol is the "good" kind, which does not contribute to plaque formation.

"The conventional wisdom is that HDL cholesterol is good for you," Abecasis said. "But in our studies we found no major impact from those genes changing HDL cholesterol levels."

The research, done in collaboration with University of North Carolina and Harvard University researchers, started with genetic studies of 8,800 people from Italy, Sweden and Finland.

The researchers examined more than 2 million genetic variations in those individuals, eventually concentrating on 25 genetic variants, which together are responsible for about 25 percent of levels of blood lipids such as cholesterol.

The study asso
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Health Level Seven Appoints John Quinn as CTO
2. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
3. Kaiser Permanente Study Shows One in Seven Women are Depressed Before, During, or After Pregnancy
4. Hospital Corporation of America Purchases Seventh CyberKnife(R) System
5. Seven Finalists Announced for 2007 Insight Award for Customer Advocacy in Healthcare
6. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
7. President Musevenis Visit Protested by HIV/AIDS Experts
8. HealthPartners is National Benchmark in Six Out of Seven Areas in National Business Coalition on Health Report
9. CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event
10. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
11. Seven Community Service Organizations Granted Over $60,000 From Delta Dental Of Illinois

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Seven New Cholesterol Genes Discovered
Seven New Cholesterol Genes Discovered
(Date:11/9/2009)...al Ambassador ,, WHITE PLAINS, N.Y., Nov. 9 /..., Fla., was born so early and with so many underde...he would survive -- or if he would ever walk, talk...ch of Dimes 2010 National Ambassador. ,, Joshu...es of motherhood and I was completely devastated. ...
(Date:11/9/2009)...wire/ -- For the third consecutive year, the Barba...e most preferred hospital for cancer care in south...al Research Corporation. ,, (Logo: http://ww...) ,, The annual survey was conducted through an...gust 2009. Survey respondents were the primary hea...
(Date:11/9/2009)...m incapacitated to working again, , ,...mulation of a certain area of the brain may prove ...German researchers. , They implanted electrodes... people. This area of the brain is part of the re... experiences and puts them in a state of pleasant ...
(Date:11/9/2009)... Phoenix House , the nation,s leading non-profi...program, announced today its appointment of Deni C...ognized leader in substance abuse treatment and re...ry 1, 2010. ,, "Dr. Deni Carise is at the ver...and her work has resulted in a significant transfo...
(Date:11/9/2009)...re-USNewswire/ -- New Mayo Clinic research has fou...ramatically reduces patient hospital stay and reco... week at the North Central Section of the American..., (Logo: http://www.newscom.com/cgi-bin/prnh/200... audio and video resources, including excerpts fro...
Breaking Medicine News(10 mins):Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3
...estchester, Ill. A study in the April 15 issue of...irst to assess the effectiveness of treating sleep... (TBI). Results indicate that treatment may result... brain-injured subjects with obstructive sleep apn...
...TANFORD, Calif. The more dots there are, the more... A new imaging technology could give scientists th... or more distinct features in or on a single cell....ty School of Medicine team led by Cathy Shachaf, P...
...WPORT BEACH, Calif., April 14 Nationwide Health P...t the Company will release its 2009 first quarter ...f trading on the New York Stock Exchange. The Com... The webcast can be accessed at the following URL ...
...shington G-2 Reports releases 2009 Laboratory mark... study from market research firm Washington G-2 Re...esting market will reach $98.4 billion in revenue ... the key factors contributing to strong market gro...
...STBROOK, Maine, April 14 IDEXX Laboratories, In... its 2009 first quarter financial results for Frid.... The Company will conduct an analyst conference c...ite, www.idexx.com . An archived edition of the...
... HARBIN, China, April 14 /PRNewswire-Asia-FirstCa...letin Board: SOKF), a leading operator of fitness ...that CEO Liu, Tong, CFO Yu, Xia,and corporate secr..., Dial-In Number(s):, * US/Canada Toll Free ...
Other Medicine News:Health News:Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms 2Health News:Stanford researchers harness nanoparticles to track cancer-cell changes 2Health News:Stanford researchers harness nanoparticles to track cancer-cell changes 3Health News:NHP Announces First Quarter Earnings Release Date and Webcast/ Conference Call 2Health News:Clinical Diagnostic Lab Testing Market to Grow Over 90% through 2017 2Health News:Clinical Diagnostic Lab Testing Market to Grow Over 90% through 2017 3Health News:SOKO Fitness & Spa Group, Inc. to hold 2009 Q3 Earnings Call on Apr. 16 2
(Date:11/9/2009)...ire-FirstCall/ -- Monsanto Company (NYSE: MON ) a...hey have entered into an agreement for Monsanto to...nter located in Chesterfield, Mo. Under the terms...rty from Pfizer for $435 million to be paid over t...t Chesterfield Village through a lease agreement, ...
(Date:11/9/2009)...wire-FirstCall/ -- Milestone Scientific Inc. (OTC ...mputer-controlled injection technologies, today an...ward-winning STA Single Tooth Anesthesia System...of TBSE titled "The Love Dentistry Fest 2009" whic... The STA System is a computer-controlled, pressu...
(Date:11/9/2009)...all/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ...pany,s Bepreve(TM) (bepotastine besilate ophthalmi...results were presented in poster sessions at the 2...rgy, Asthma & Immunology (ACAAI) in Miami Beac...eatment of Ocular Itching with Bepotastine Besilat...
Breaking Medicine Technology:Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Solutions for Better Care for the Elderly 59924 1Solutions for Better Care for the Elderly 59924 2Solutions for Better Care for the Elderly 59924 3ERT to Announce 2009 Third Quarter Results on October 29 2009 14568 1ERT to Announce 2009 Third Quarter Results on October 29 2009 14568 2Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 14565 1Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 14565 2Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 14565 3
...ll., May 8 Siemens Healthcare and,Laboratory Corp...announced,that they have entered a non-exclusive a...elop new clinical diagnostic tests in the areas of...gy and diabetes. Under the,agreement, initial disc...uld make the biggest impact to patient care., (Lo...
...onn., May 8 VION PHARMACEUTICALS,INC. (Nasdaq: V...-sponsored,Phase I/II clinical trial of its lead a...ination with cytarabine in elderly patients with,p...L) and high-risk,myelodysplastic syndromes (MDS). ...f Ellen K. Ritchie, M.D. at The Weill-Cornell Medi...
Other Medicine Technology:Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: